<!DOCTYPE html>
<html>
<head>
<title>MaxLinear, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="https://investors.maxlinear.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://investors.maxlinear.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/1995">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/1995">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/1996">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/1996">Consolidated Balance Sheets</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/1997">Consolidated Balance Sheet (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/1998">Consolidated Statement of Operations</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/1999">Consolidated Statements of Comprehensive Income (Loss)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2000">Consolidated Statement of Comprehensive Income (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2001">Consolidated Statement of Stockholder's Equity Statement</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2002">Consolidated Statements of Cash Flows</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2003">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2003">Organization and Summary of Significant Accounting Policies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2004">Net Income (Loss) Per Share</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2005">Restructuring Activity</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2006">Goodwill and Intangible Assets</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2007">Financial Instruments</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2008">Balance Sheet Details</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2009">Debt and Interest Rate Swap</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2010">Stock-Based Compensation and Employee Benefit Plans</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2011">Income Taxes</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2012">Concentration of Credit Risk, Significant Customers and Geographic Information</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2013">Revenue from Contracts with Customers</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2014">Leases</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2015">Commitments and Contingencies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2016">Subsequent Events (Notes)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2017">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2017">Organization and Summary of Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2018">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2018">Net Income (Loss) Per Share (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2019">Restructuring Activity (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2020">Goodwill and Intangibles Assets (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2021">Financial Instruments (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2022">Balance Sheet Details (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2023">Debt and Interest Rate Swap (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2024">Stock-Based Compensation and Employee Benefit Plans (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2025">Concentration of Credit Risk, Significant Customers and Geographic Information (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2026">Revenue from Contracts with Customers (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2027">Leases (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2028">Commitments and Contingencies (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2029">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2029">Net Income (Loss) Per Share (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2030">Net Income (Loss) Per Share (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2031">Restructuring Activity (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2032">Restructuring Activities (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2033">Restructuring Activity (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2034">Goodwill and Intangibles Assets (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2035">Goodwill and Intangibles Assets (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2036">Goodwill and Intangibles Assets (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2037">Goodwill and Intangibles Assets (Details 4)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2038">Goodwill and Intangibles Assets (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2039">Financial Instruments (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2040">Financial Instruments (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2041">Financial Instruments (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2042">Financial Instruments - Additional Information (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2043">Balance Sheet Details - Cash and Investments (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2044">Balance Sheet Details - Inventory (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2045">Balance Sheet Details - Property and Equipment (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2046">Balance Sheet Details- Accrued Price Protection Liability (Details 5)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2047">Balance Sheet Details - Accrued Expenses (Details 6)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2048">Balance Sheet Details Balance Sheet Details - AOCI (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2049">Debt and Interest Rate Swap (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2050">Stock-Based Compensation and Employee Benefit Plans - Additional Information (Details Textuals)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2051">Stock-Based Compensation and Employee Benefit Plans - Expense by Type (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2052">Stock-Based Compensation and Employee Benefit Plans - Awards (Details 2)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2053">Stock-Based Compensation and Employee Benefit Plans - ESPP (Details 3)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2054">Stock-Based Compensation and Employee Benefit Plans - Stock Options (Details 4)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2055">Income Taxes - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2056">Concentration of Credit Risk, Significant Customers and Geographic Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2057">Revenue from Contracts with Customers (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2058">Leases (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2059">Commitments and Contingencies (Details 1)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/quarterly-reports/xbrl_doc_only/2060">Subsequent Events (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Balance Sheet Details</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>